PCNA and prostate carcinoma: Additionally, it was found that treatment of PC3 prostate cancer cell lines with fangchinoline leads to an increase in protein p27 expression, the inhibition of cyclin-regulated signaling pathways associated with the arrest of the G1/S phase, and inhibition of cyclin D and proliferating cell nuclear antigen expression [30].